These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 14101486)
1. THE CONCENTRATION OF VASOPRESSIN IN THE BLOOD AND THE RATE OF URINARY EXCRETION OF THE HORMONE BY PATIENTS WITH CIRRHOSIS OF THE LIVER. LEE J; KERR DN Clin Sci; 1963 Dec; 25():375-84. PubMed ID: 14101486 [No Abstract] [Full Text] [Related]
2. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. Ferguson JW; Therapondos G; Newby DE; Hayes PC Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis. Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829 [TBL] [Abstract][Full Text] [Related]
4. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D; Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290 [TBL] [Abstract][Full Text] [Related]
5. Improved method and its clinical application of a radioimmunoassay of arginine vasopressin in human serum. Wagner H; Maier V; Franz HE Horm Metab Res; 1977 May; 9(3):223-7. PubMed ID: 885476 [TBL] [Abstract][Full Text] [Related]
6. Correction of impaired water excretion in cirrhosis of the liver by alcohol ingestion or expansion of extracellular fluid volume: the role of the antidiuretic hormone. BIRCHARD WH; SAXON L; STRAUSS MB Trans Assoc Am Physicians; 1956; 69():222-8. PubMed ID: 13380966 [No Abstract] [Full Text] [Related]
7. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites. Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330 [TBL] [Abstract][Full Text] [Related]
10. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Fernández-Varo G; Oró D; Cable EE; Reichenbach V; Carvajal S; de la Presa BG; Wiśniewski K; Ginés P; Harris G; Jiménez W Hepatology; 2016 Jan; 63(1):207-16. PubMed ID: 26403564 [TBL] [Abstract][Full Text] [Related]
11. The effects of pitressin on the metabolism and excretion of water and electrolytes in normal subjects and patients with cirrhosis and ascites. NELSON WP; WELT LG J Clin Invest; 1952 Apr; 31(4):392-400. PubMed ID: 14917759 [No Abstract] [Full Text] [Related]
12. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites. Leehey DJ; Gollapudi P; Deakin A; Reid RW J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589 [TBL] [Abstract][Full Text] [Related]
13. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome. Esteva-Font C; Baccaro ME; Fernández-Llama P; Sans L; Guevara M; Ars E; Jiménez W; Arroyo V; Ballarín JA; Ginès P Hepatology; 2006 Dec; 44(6):1555-63. PubMed ID: 17133493 [TBL] [Abstract][Full Text] [Related]
14. [Effect of the antidiuretic hormone on carbon tetrachloride induced cirrhosis in rats]. HANKISS J Kiserl Orvostud; 1956 Sep; 8(5):453-7. PubMed ID: 13386044 [No Abstract] [Full Text] [Related]
16. [Urinary excretion of magnesium in patients with liver cirrhosis treated with oral diuretics. Its variation through vasopressin]. Bardi A; Merino I; Rendic Y; Generini G Rev Med Chil; 1968 Jun; 96(6):415-9. PubMed ID: 5730619 [No Abstract] [Full Text] [Related]
17. Vasopressin in cirrhosis and sepsis: physiology and clinical implications. Wagener G; Bakker J Minerva Anestesiol; 2015 Dec; 81(12):1377-83. PubMed ID: 25384691 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia. Dahl E; Gluud LL; Kimer N; Krag A Aliment Pharmacol Ther; 2012 Oct; 36(7):619-26. PubMed ID: 22908905 [TBL] [Abstract][Full Text] [Related]
19. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Pedersen RS; Bentzen H; Bech JN; Nyvad O; Pedersen EB Kidney Int; 2003 Apr; 63(4):1417-25. PubMed ID: 12631357 [TBL] [Abstract][Full Text] [Related]
20. Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system. Krag A; Møller S; Pedersen EB; Henriksen JH; Holstein-Rathlou NH; Bendtsen F Liver Int; 2010 Oct; 30(9):1364-70. PubMed ID: 20731774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]